PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCC

Clinical trial NCT02544880 · COMPLETED

Trial details

NCT number: NCT02544880
Sponsor: Donald T. Weed, MD, FACS
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma Head and Neck Cancer

Start date: 2016-04-25
Primary completion: 2019-06-02
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.